Avanos Medical AVNS Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Reportable segment operating income (loss) by Business | ||||||
| PM&R | -$1.8M-1,000% | $5.2M+33.3% | $2M+150% | $1.8M+1,700% | $200K+110% | |
| Total Specialty Nutrition Systems | $23.1M+9.5% | $20.5M-18.0% | $23M+23.7% | $18M-17.4% | $21.1M+37.0% | |
| Other segment items by Business | ||||||
| PM&R | $0— | -$100K— | $0— | $0— | $0— | |
| Total Specialty Nutrition Systems | -$100K0.0% | —— | -$400K— | $200K— | -$100K— | |
| General expenses by Business | ||||||
| PM&R | -$12.3M+3.1% | -$10.9M-29.8% | -$11.6M-22.1% | -$13.3M-40.0% | -$12.7M-19.8% | |
| Total Specialty Nutrition Systems | -$20.8M-18.9% | -$16.2M-33.9% | -$17.5M-28.7% | -$18.3M-34.6% | -$17.5M-14.4% | |
| Currency translation adjustment by Business | ||||||
| PM&R | -$900K-200% | $800K— | $4.4M— | -$2.3M— | -$300K— | |
| Total Specialty Nutrition Systems | $0— | $0— | $0— | $0— | $0— | |
| Advertising, promotion and selling expenses by Business | ||||||
| PM&R | -$15.9M-6.7% | -$16.1M+19.1% | -$15.5M+13.9% | -$15.8M+22.5% | -$14.9M+24.4% | |
| Total Specialty Nutrition Systems | -$15.1M-28.0% | -$15.8M+13.2% | -$13.3M+15.3% | -$12.7M+21.1% | -$11.8M+30.6% | |
| Cost of goods sold by Business | ||||||
| PM&R | -$21.7M-4.8% | -$20.8M+1.4% | -$21.9M-0.5% | -$22.3M-5.7% | -$20.7M-2.0% | |
| Total Specialty Nutrition Systems | -$48M-36.4% | -$46.8M-29.3% | -$44.3M-22.7% | -$38.8M-20.9% | -$35.2M-12.8% | |
| Depreciation and amortization expense by Business | ||||||
| PM&R | -$3.7M+5.1% | -$3.6M-9.1% | -$3.6M-5.9% | -$3.6M-9.1% | -$3.9M-14.7% | |
| Total Specialty Nutrition Systems | -$6.1M-22.0% | -$5.8M-56.8% | -$5M-16.3% | -$4.6M-9.5% | -$5M-19.0% | |
| Distribution by Business | ||||||
| PM&R | -$3.2M-18.5% | -$3.7M-23.3% | -$3.1M-34.8% | -$3.1M-10.7% | -$2.7M-12.5% | |
| Total Specialty Nutrition Systems | -$7.1M-12.7% | -$6.3M0.0% | -$6.1M-17.3% | -$6.2M-5.1% | -$6.3M+13.7% | |
| Research and development expenses by Business | ||||||
| PM&R | -$1.3M-18.2% | -$1.3M-8.3% | -$1.3M+35.0% | -$1.1M+47.6% | -$1.1M+45.0% | |
| Total Specialty Nutrition Systems | -$3.7M+9.8% | -$3.9M+11.4% | -$4.4M+6.4% | -$4.3M-7.5% | -$4.1M+2.4% | |
| Goodwill by Business | ||||||
| PM&R | $52.7M-58.9% | $53.6M-58.1% | $52.8M— | $53.6M— | $128.3M— | |
| Total Specialty Nutrition Systems | $341.3M+4.2% | $341.3M+4.2% | $341.6M— | $327.6M— | $327.6M— | |
| Net Sales by Product | ||||||
| Enteral feeding | $84.6M+13.6% | $83M+10.7% | $82.7M+14.9% | $74.5M+2.5% | $74.5M+6.4% | |
| Neonate solutions | $39.4M+48.1% | $32.1M+3.9% | $31.3M+19.5% | $28.2M+12.8% | $26.6M+8.1% | |
| Radiofrequency ablation | $34.5M+8.8% | $36.9M+8.2% | $34.6M+10.5% | $35.8M+13.7% | $31.7M+8.2% | |
| Surgical pain and recovery | $21.8M-11.0% | $24.7M-7.5% | $24.4M-7.9% | $25.2M-9.4% | $24.5M-9.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Avanos Medical break its business down?
- Avanos Medical (AVNS) reports reportable segment operating income (loss) by business across 2 parts — PM&R and Total Specialty Nutrition Systems. Each is extracted from the segment footnotes and tracked over time.
- Where does Avanos Medical's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Avanos Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
